Pre-deployment differences in glucocorticoid sensitivity of leukocytes in soldiers developing symptoms of PTSD, depression or fatigue persist after return from military deployment

Psychoneuroendocrinology

Volumn 51, Issue , 2015, Pages 513-524

  van Zuiden, Mirjam ^a   Kavelaars, Annemieke ^b   Vermetten, Eric ^c,d,e,f   Olff, Miranda ^a,e   Geuze, Elbert ^c,d   Heijnen, Cobi ^b,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TEXAS   (United States)

^c Ministerie van Defensie   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e ARQ PSYCHOTRAUMA EXPERT GROUP   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Combat; Depression; Fatigue; Glucocorticoid receptor; PTSD; Stress

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; FATIGUE; FEMALE; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LONGITUDINAL STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MILITARY DEPLOYMENT; MONOCYTE; POSTTRAUMATIC STRESS DISORDER; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SOLDIER; SYMPTOM; T LYMPHOCYTE; ADOLESCENT; DRUG EFFECTS; IMMUNOLOGY; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

ADOLESCENT; ADULT; DEPRESSION; DEXAMETHASONE; FATIGUE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MILITARY PERSONNEL; MONOCYTES; PROSPECTIVE STUDIES; STRESS DISORDERS, POST-TRAUMATIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 84920581155     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.09.014     Document Type: Article

References (47)

1. Aben I., Verhey F., Lousberg R., Lodder J., Honig A. Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90, and Hamilton depression rating scale as screening instruments for depression in stroke patients. Psychosomatics 2002, 43:386-393.
2. Arrindell W.A., Ettema J.H.M. Symptom Checklist: Handleiding Bij Een Multidimensionele Psychopathologie-Indicator 2003, Swets & Zeitlinger, Lisse, The Netherlands.
3. Bauer M.E., Papadopoulos A., Poon L., Perks P., Lightman S.L., Checkley S., Shanks N. Altered glucocorticoid immunoregulation in treatment resistant depression. Psychoneuroendocrinology 2003, 28:49-65.
4. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., Tang Y., Gillespie C.F., Heim C.M., Nemeroff C.B., Schwartz A.C., Cubells J.F., Ressler K.J. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
5. Bremner J.D., Bolus R., Mayer E.A. Psychometric properties of the Early Trauma Inventory-Self Report. J. Nerv. Ment. Dis. 2007, 195:211-218.
6. Buchmann A.F., Holz N., Boecker R., Blomeyer D., Rietschel M., Witt S.H., Schmidt M.H., Esser G., Banaschewski T., Brandeis D., Zimmermann U.S., Laucht M. Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthood. Eur. Neuropsychopharmacol. 2014, 24:837-845.
7. Carvalho L.A., Juruena M.F., Papadopoulos A.S., Poon L., Kerwin R., Cleare A.J., Pariante C.M. Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression. Neuropsychopharmacology 2008, 33:3182-3189.
8. Cohen S., Janicki-Deverts D., Doyle W.J., Miller G.E., Frank E., Rabin B.S., Turner R.B. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5995-5999.
9. de Kloet C.S., Vermetten E., Bikker A., Meulman E., Geuze E., Kavelaars A., Westenberg H.G.M. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol. Psychiatry 2007, 12:443-453.
10. De Vries M., Soetekouw P.M.M.B., Van D.M., Bleijenberg G. Fatigue in Cambodia veterans. QJM 2000, 93:283-289.
11. de Vries M., Soetekouw P.M., van d.M., Bleijenberg G. The role of post-traumatic stress disorder symptoms in fatigued Cambodia veterans. Mil. Med. 2002, 167:790-794.
12. Gaab J., Rohleder N., Heitz V., Schad T., Engert V., Schurmeyer T.H., Ehlert U. Enhanced glucocorticoid sensitivity in patients with chronic fatigue syndrome. Acta Neuropsychiatrica 2003, 15:184-191.
13. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr. 2009, 14:13-24.
14. Heim C., Ehlert U., Hellhammer D.H. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
15. Hovens J.E., Bramsen I., van d.P. Self-rating inventory for posttraumatic stress disorder: review of the psychometric properties of a new brief Dutch screening instrument. Percept. Mot. Skills 2002, 94:996-1008.
16. Hovens J.E., van der Ploeg H.M., Klaarenbeek M.T., Bramsen I., Schreuder J.N., Rivero V.V. The assessment of posttraumatic stress disorder: with the Clinician Administered PTSD Scale: Dutch results. J. Clin. Psychol. 1994, 50:325-340.
17. Kang H.K., Natelson B.H., Mahan C.M., Lee K.Y., Murphy F.M. Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf war veterans: a population-based survey of 30,000 veterans. Am. J. Epidemiol. 2003, 157:141-148.
18. Klengel T., Mehta D., Anacker C., Rex-Haffner M., Pruessner J.C., Pariante C.M., Pace T.W., Mercer K.B., Mayberg H.S., Bradley B., Nemeroff C.B., Holsboer F., Heim C.M., Ressler K.J., Rein T., Binder E.B. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 2013, 16:33-41.
19. Lehrner A., Yehuda R. Biomarkers of PTSD: military applications and considerations. Eur. J. Psychotraumatol. 2014, 5. eCollection 2014. 10.3402/ejpt.v5.23797.
20. McFarlane A.C., Barton C.A., Yehuda R., Wittert G. Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology 2011, 36:720-727.
21. Miller G.E., Rohleder N., Cole S.W. Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom. Med. 2009, 71:57-62.
22. Miller G.E., Chen E., Sze J., Marin T., Arevalo J.M., Doll R., Ma R., Cole S.W. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol. Psychiatry 2008, 64:266-272.
23. Miller G.E., Cohen S., Ritchey A.K. Chronic psychological stress and the regulation of pro-inflammatory cytokines: a glucocorticoid-resistance model. Health Psychol. 2002, 21:531-541.
24. Miller G.E., Rohleder N., Stetler C., Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom. Med. 2005, 67:679-687.
25. Morris M.C., Compas B.E., Garber J. Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: a systematic review and meta-analysis. Clin. Psychol. Rev. 2012, 32:301-315.
26. Pariante C.M., Miller A.H. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol. Psychiatry 2001, 49:391-404.
27. Reijnen A., Rademaker A.R., Vermetten E., Geuze E. Prevalence of mental health symptoms in Dutch military personnel returning from deployment to Afghanistan: a 2-year longitudinal analysis. Eur. Psychiatry 2014, pii: S0924-9338(14)00093-5, [Epub ahead of print]. 10.1016/j.eurpsy.2014.05.003.
28. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2010, 35:104-114.
29. Rohleder N., Marin T.J., Ma R., Miller G.E. Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways. J. Clin. Oncol. 2009, 27:2909-2915.
30. Schmitz N., Kruse J., Heckrath C., Alberti L., Tress W. Diagnosing mental disorders in primary care: the General Health Questionnaire (GHQ) and the Symptom Check List (SCL-90-R) as screening instruments. Soc. Psychiatry Psychiatr. Epidemiol. 1999, 34:360-366.
31. Shek D., Ma C. Longitudinal data analyses using linear mixed models in SPSS: concepts, procedures and illustrations. Sci. World J. 2011, 11:42-76.
32. Silverman M.N., Heim C.M., Nater U.M., Marques A.H., Sternberg E.M. Neuroendocrine and immune contributors to fatigue. PM R. 2010, 2:338-346.
33. Stetler C., Miller G.E. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 2011, 73:114-126.
34. Strik J.J., Honig A., Lousberg R., Denollet J. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001, 42:423-428.
35. Tak L.M., Cleare A.J., Ormel J., Manoharan A., Kok I.C., Wessely S., Rosmalen J.G. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol. Psychol. 2011, 87:183-194.
36. ter Wolbeek M., van Doornen L.J., Schedlowski M., Janssen O.E., Kavelaars A., Heijnen C.J. Glucocorticoid sensitivity of immune cells in severely fatigued adolescent girls: a longitudinal study. Psychoneuroendocrinology 2008, 33:375-385.
37. Thomas J.L., Wilk J.E., Riviere L.A., McGurk D., Castro C.A., Hoge C.W. Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq. Arch. Gen. Psychiatry 2010, 67:614-623.
38. van Zelst W.H., de Beurs E., Beekman A.T., Deeg D.J., Bramsen I., van Dyck R. Criterion validity of the self-rating inventory for posttraumatic stress disorder (SRIP) in the community of older adults. J. Affect. Disord. 2003, 76:229-235.
39. van Zuiden M., Kavelaars A., Geuze E., Olff M., Heijnen C.J. Predicting PTSD: pre-existing vulnerabilities in glucocorticoid-signaling and implications for preventive interventions. Brain Behav. Immun. 2013, 30:12-21.
40. van Zuiden M., Geuze E., Maas M., Vermetten E., Heijnen C.J., Kavelaars A. Deployment-related severe fatigue with depressive symptoms is associated with increased glucocorticoid binding to peripheral blood mononuclear cells. Brain Behav. Immun. 2009, 23:1132-1139.
41. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Heijnen C.J., Kavelaars A. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am. J. Psychiatry 2011, 168:89-96.
42. van Zuiden M., Heijnen C.J., van d.S., Amarouchi K., Maas M., Vermetten E., Geuze E., Kavelaars A. Cytokine production by leukocytes of military personnel with depressive symptoms after deployment to a combat-zone: a prospective, longitudinal study. PLoS ONE 2011, 6:e29142.
43. van Zuiden M., Geuze E., Willemen H.L., Vermetten E., Maas M., Amarouchi K., Kavelaars A., Heijnen C.J. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol. Psychiatry 2011, 71:309-316.
44. van Zuiden M., Heijnen C.J., Maas M., Amarouchi K., Vermetten E., Geuze E., Kavelaars A. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: a prospective study. Psychoneuroendocrinology 2012, 37:1822-1836.
45. Vercoulen J.H.M.M., Alberts M., Bleijenberg G. The checklist individual strength. Gedragstherapie 1999, 32:131-136.
46. West B.T. Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval. Health Prof. 2009, 32:207-228.
47. Yehuda R., Yang R.K., Golier J.A., Grossman R.A., Bierer L.M., Tischler L. Effect of sertraline on glucocorticoid sensitivity of mononuclear leukocytes in post-traumatic stress disorder. Neuropsychopharmacology 2006, 31:189-196.